MedPath

Phenylpropanolamine

Generic Name
Phenylpropanolamine
Drug Type
Small Molecule
Chemical Formula
C9H13NO
CAS Number
14838-15-4
Unique Ingredient Identifier
33RU150WUN

Overview

Phenylpropanolamine is a sympathomimetic agent that acts as a nonselective adrenergic receptor agonist and norepinephrine reuptake inhibitor. It has been used as a decongestant and appetite suppressant. Currently, it is withdrawn from the market in Canada and the United States due to the risk for hemorrahgic strokes.

Indication

For the treatment of nasal congestion, control of urinary incontinence, priapism and obesity.

Associated Conditions

  • Allergy-Induced Respiratory Symptoms
  • Bronchitis
  • Common Cold
  • Cough
  • Nasal Congestion
  • Rhinorrhoea
  • Excess mucus or phlegm

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2016/04/14
Phase 1
Active, not recruiting
CrystalGenomics, Inc.
2016/04/13
Phase 1
UNKNOWN
CrystalGenomics, Inc.

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Pegasus Laboratories, Inc.
49427-921
ORAL
50 1 in 1 1
4/21/2025
Pegasus Laboratories, Inc.
49427-920
ORAL
25 1 in 1 1
4/18/2025
Pegasus Laboratories, Inc.
49427-922
ORAL
75 1 in 1 1
4/21/2025

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
JEM C P P TAB
N/A
N/A
N/A
8/1/1979
UNI-VASIN LIQUID
N/A
N/A
N/A
6/14/1979
D.P.P SYRUP
N/A
N/A
N/A
7/25/1984
C.P.P. SYRUP
N/A
N/A
N/A
7/28/1997
NEO B P P TAB
N/A
N/A
N/A
4/12/1984
BPP SYRUP
N/A
N/A
N/A
4/27/1979

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
DIMETAPP COUGH & COLD LIQUI-GELS - CAP
whitehall-robins inc.
02215314
Capsule - Oral
25 MG
10/22/1996
ORADRINE-2 TAB
pharmetics (2011) inc
00763519
Tablet - Oral
25 MG
12/31/1989
CALDOMINE DH ADULTE
technilab pharma inc.
00550485
Liquid - Oral
25 MG / 5 ML
12/31/1981
DECONGESTANT ANTIHISTAMINIC SYRUP
00576689
Elixir - Oral
5 MG / 5 ML
12/31/1984
ORNADE AF LIQUID
smithkline beecham pharma division of smithkline beecham inc
01918125
Liquid - Oral
15 MG / 5 ML
12/31/1993
SINE-OFF N.D. TAB
smithkline consumer products
00755990
Tablet - Oral
18.75 MG / TAB
12/31/1988
EMERCIDIN D TAB
pharmetics (2011) inc
00763519
Tablet - Oral
25 MG
12/31/1989
TRISULFAMINIC TAB
shepherd pharmaceuticals inc.
00889210
Tablet - Oral
12.5 MG
12/31/1959
TRIAMINIC TIME RELEASE TAB
novartis consumer health canada inc.
01906593
Tablet (Extended-Release) - Oral
50 MG
12/31/1992
TRIAMINIC EXPECTORANT DH SYRUP
novartis consumer health canada inc.
01906615
Syrup - Oral
12.5 MG / 5 ML
12/31/1993

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.